sarcoma Flashcards
synovial sarcoma systemic regimens
Adriamycin, ifosfamide, mesna (AIM)
High dose ifosfamide
SOC for osteogenic osteosarcoma
Neoadjuvant cisplatin, doxorubicin, and high dose methotrexate (MAP)
Surgery
Additional adjuvant MAP chemotherapy (systemic disease that requires intense systemic chemotherapy)
First line chemotherapy for osteogenic osteosarcoma
Neoadjuvant cisplatin, doxorubicin, and high dose methotrexate (MAP)
Management of low-grade localized chondrosarcoma
Upfront surgical resection
Given low grade, observation with serial imaging
Giant cell tumor management
Upfront surgery
*no role for radiation or chemotherapy
Angiosarcoma of the breast management
mastectomy alone
Preferred second line for GIST
Repritinib (INVICTUS)
Second line for dedifferentiated liposarcoma
Eribulin
management of recurrent desmoid tumor
sorafenib
Management of recurrent giant cell tumor
Denosumab
Firstline for GIST harboring PDGFRA exon 18 mutation
avapritinib
Trabectedin SE to know
Rhabdomyolysis
First line for metastatic osteosarcoma
IF >40, cisplatin/doxorubicin without high dose methotrexate
Management of desmoid fibromatosis in pregnant patient
Monitor (DF that develops within 6 months of pregnancy may regress without intervention, so watchful waiting appropriate)
GIST management with c-kit exon 9 mutation
higher starting dose of imatinib (400 mg BID) (higher mitotic rate and increased recurrence risk)